Wednesday, March 08, 2017 2:57:08 PM
massive moves by FDA in MARCH FDA Lifts Clinical Hold
Glenmark gets USFDA nod to start phase-II clinical trials for respiratory drug
08 Mar 2017 07:40 livemint.com
Seattle Genetics to Resume Trials as FDA Lifts Clinical Hold
07 Mar 2017 22:59 Medscape
FDA Lifts Clinical Hold on Seattle Genetics Trials
07 Mar 2017 15:19 Genetic Engineering News
Advaxis stock jumps 10% after FDA okays clinical trials for Amgen-partnered cancer drug
06 Mar 2017 13:49 MarketWatch
Seattle Genetics to resume trials as FDA lifts clinical hold
06 Mar 2017 12:55 Reuters
FDA Lifts Clinical Hold on Seattle Genetics’ Phase 1 Trials of Vadastuximab Talirine
06 Mar 2017 12:03 PharmiWeb.com
MorphoSys Partner to Start New Phase 3 Clinical Trials with Gantenerumab in Alzheimer's Disease
06 Mar 2017 07:16 MarketWatch.com
Obtains Clinical Trials Approval for Rivastigmine Multi-day Patch in Germany
06 Mar 2017 04:19 4-traders
Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate
06 Mar 2017 00:16 News-Medical.net
Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia
06 Mar 2017 00:08 News-Medical.net
ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients
06 Mar 2017 00:08 News-Medical.net
Doctors face challenges getting clinical trials for children with cancer
04 Mar 2017 01:49 KPHO
The future of patient-centricity in clinical trials?
03 Mar 2017 15:43 Xconomy
Investor's Guide To Clinical Trials: Phase Success Rates For Introductory Pipeline Analysis
02 Mar 2017 23:20 Seeking Alpha
TAKE Solutions sees biz opportunity in clinical trials outsourcing
01 Mar 2017 17:05 The Hindu Business Line
Are we moving fast enough? ARG talks rare disease clinical trials
01 Mar 2017 10:01 OutSourcing-Pharma.com
Glenmark gets USFDA nod to start phase-II clinical trials for respiratory drug
08 Mar 2017 07:40 livemint.com
Seattle Genetics to Resume Trials as FDA Lifts Clinical Hold
07 Mar 2017 22:59 Medscape
FDA Lifts Clinical Hold on Seattle Genetics Trials
07 Mar 2017 15:19 Genetic Engineering News
Advaxis stock jumps 10% after FDA okays clinical trials for Amgen-partnered cancer drug
06 Mar 2017 13:49 MarketWatch
Seattle Genetics to resume trials as FDA lifts clinical hold
06 Mar 2017 12:55 Reuters
FDA Lifts Clinical Hold on Seattle Genetics’ Phase 1 Trials of Vadastuximab Talirine
06 Mar 2017 12:03 PharmiWeb.com
MorphoSys Partner to Start New Phase 3 Clinical Trials with Gantenerumab in Alzheimer's Disease
06 Mar 2017 07:16 MarketWatch.com
Obtains Clinical Trials Approval for Rivastigmine Multi-day Patch in Germany
06 Mar 2017 04:19 4-traders
Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate
06 Mar 2017 00:16 News-Medical.net
Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia
06 Mar 2017 00:08 News-Medical.net
ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients
06 Mar 2017 00:08 News-Medical.net
Doctors face challenges getting clinical trials for children with cancer
04 Mar 2017 01:49 KPHO
The future of patient-centricity in clinical trials?
03 Mar 2017 15:43 Xconomy
Investor's Guide To Clinical Trials: Phase Success Rates For Introductory Pipeline Analysis
02 Mar 2017 23:20 Seeking Alpha
TAKE Solutions sees biz opportunity in clinical trials outsourcing
01 Mar 2017 17:05 The Hindu Business Line
Are we moving fast enough? ARG talks rare disease clinical trials
01 Mar 2017 10:01 OutSourcing-Pharma.com
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM

